Graham Partners, a Pennsylvania-based private investment firm focused on industrial technology and manufacturing businesses, has made an investment in Rhythmlink International LLC, a medical device manufacturing company.

Rhythmlink offers a line of consumable neurodiagnostic devices for critical care, electroencephalography, intraoperative neuromonitoring, the ER and the ICU. Graham’s investment in Rhythmlink looks to drive the company’s growth in product innovation and quality.

“Graham is an excellent partner for us because of their experience in medical technology and healthcare, and we see this as a growth opportunity for us to continue to innovate beyond our current capabilities,” says Shawn Regan, CEO and co-founder of Rhythmlink.